BiotechTube
Cerbios-Pharma

Cerbios-Pharma

Barbengo, Switzerland· Est.
cerbios.swiss
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $27.5M

Overview

Cerbios-Pharma is a well-established, private Swiss CDMO offering end-to-end services from development to commercial manufacturing of complex drug substances and products. Its core competencies span chemical synthesis, biological manufacturing (including proteins/antibodies and living microorganisms), and a strong project management framework to guide client programs. The company is executing a strategic investments plan through 2026, indicating growth ambitions in the specialized CDMO space for potent and biologic drugs. Its business model is purely service-based, generating revenue through client contracts.

Small MoleculesAntibodies

Technology Platform

Integrated CDMO platforms for Chemical Synthesis (HPAPIs, ADC payloads/linkers), Biological Manufacturing (Proteins/Antibodies, ADC conjugation), and Living Microorganisms. Supported by a dedicated Project Management Office.

Funding History

2
Total raised:$27.5M
Series A$25M
Grant$2.5M

Opportunities

Strong demand in high-growth CDMO niches like HPAPIs and Antibody-Drug Conjugates (ADCs), driven by the oncology pipeline.
The 'Living Microorganisms' capability positions the company in the emerging microbiome therapy space.
An active investment plan through 2026 indicates capacity expansion to capture this demand.

Risk Factors

Faces client concentration risk and intense competition from global CDMOs.
Operational execution risk is high due to the complex and potent nature of the products manufactured.
Revenue is dependent on the health of the broader biopharma R&D pipeline and funding environment.

Competitive Landscape

Operates in a crowded global CDMO market, competing with large players like Lonza, Catalent, and Samsung Biologics, as well as specialized HPAPI/ADC CDMOs. Differentiation is based on integrated chemical/biological capabilities, Swiss quality reputation, and the niche 'Living Microorganisms' offering.

More companies in Switzerland →